Table 2.
General characteristics of patients included in the study and antibiotic prophylaxis
| Antibiotic | None n=20 | Levofloxacin n=1 | Ciprofloxacin n=5 | Ciprofloxacin +metronidazole n=1 |
Ciprofloxacin +SMX/TMP n=23 |
| Posology | N/A | 750 mg DIE (n=1) | 750 mg BID (n=1) 500 mg BID (n=4) |
750 mg BID +500 mg TID (n=1) |
500 mg BID+800/160 mg BID (n=18) 500 mg BID+800/160 mg DIE (n=3) 500 mg DIE +800/160 mg DIE (n=1) 500 mg BID+400/80 mg DIE (n=1) |
| Average duration (days) | N/A | 11 | 4.8 | 5 | 3.3 |
| Patient characteristics (n=50) | |||||
| Male | 17 | 0 | 2 | 1 | 12 |
| Female | 3 | 1 | 3 | 0 | 11 |
| Age, median (years) | 50 | 79 | 55 | 33 | 61 |
| Leeches | |||||
| Quantity of leeches dispensed | 60 | 169 | 78 | 75 | 59 |
| Average duration (days) | 4.2 | 11 | 4.8 | 5 | 3.3 |
BID, twice a day; DIE, once a day; N/A, not applicable; SMX/TMP, sulfamethoxazole/trimethoprim; TID, three times a day.